Literature DB >> 23155491

Inflammatory bowel disease treatment and non-melanoma skin cancer: a case report.

Jacqueline F De Luca1, Yun Sun Lee, Douglas Johnson.   

Abstract

Immunosuppressant medications for Inflammatory Bowel Disease can help with both symptoms and disease progression. However, like immunosuppressants used in transplant patients, they are now suspect of contributing to nonmelenoma skin cancer (NMSC). Presented is a case of a 57-year-old Jewish man with Crohn's Disease who was diagnosed with a total of 84 NMSCs. We hope to elucidate the risk of immunosuppressants, particularly the thiopurines, on the development of NMSC.

Entities:  

Keywords:  Crohn's Disease; Inflammatory Bowel Disease; Nonmelanoma Skin Cancer; Thiopurines; Ulcerative Colitis

Mesh:

Substances:

Year:  2012        PMID: 23155491      PMCID: PMC3497917     

Source DB:  PubMed          Journal:  Hawaii J Med Public Health        ISSN: 2165-8242


  3 in total

Review 1.  Epidemiology of nonmelanoma skin cancer.

Authors:  S S Strom; Y Yamamura
Journal:  Clin Plast Surg       Date:  1997-10       Impact factor: 2.017

2.  Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease.

Authors:  Millie D Long; Hans H Herfarth; Clare A Pipkin; Carol Q Porter; Robert S Sandler; Michael D Kappelman
Journal:  Clin Gastroenterol Hepatol       Date:  2010-01-16       Impact factor: 11.382

3.  Risk factors for small bowel cancer in Crohn's disease.

Authors:  B A Lashner
Journal:  Dig Dis Sci       Date:  1992-08       Impact factor: 3.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.